Table 1. Clinical characteristics of the study subjects.
Variable | BPH | Pca | p-value | |
---|---|---|---|---|
Patient number | 53 | 63 | ||
Age (y) | 70.85±8.16 | 67.27±6.76 | 0.011* | |
PSA (ng/mL) | 1.87 (0.96–4.97) | 11.62 (5.15–17.90) | <0.001† | |
Operation | ||||
TURP | 53 (100.0) | 4 (6.3) | ||
Radical prostatectomy | 59 (93.7) | |||
Gleason score | ||||
7 (3+4) | 41 (65.1) | |||
7 (4+3) | 16 (25.4) | |||
≥8 | 6 (9.5) | |||
Stage | ||||
T2 | 29 (46.0) | |||
T3 | 28 (44.4) | |||
T4 or metastasis | 6 (9.5) |
Values are presented as mean±standard deviation, median (interquartile range), or number (%).
BPH, benign prostate hyperplasia; PCa, prostate cancer; PSA, prostate-specific antigen; TURP, transurethral resection of the prostate.
p-values were obtained using the *Student’s t-test and the †Mann–Whitney U-test.